Market Watch Ardelyx stock rises as FDA grants appeal for new drug application for Xphozah Ardelyx Inc. ARDX, +5.02% stock is up 5.2% in premarket trades on Thursday after the Waltham, Mass., biopharmaceutical company said the U.S. Food and Drug…breakingnow_w51jcqDecember 29, 2022
